Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions 
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak 
US Yen Intervention Unlikely to Deliver Lasting Recovery, Yardeni Says 
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead 
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
BOJ Signals Faster Rate Hikes as Inflation Risks Raise September Move Odds 
S&P 500, Nasdaq Slip as Oil Jumps on Iran Tensions 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk 
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Austal Shares Surge 16% as Hanwha Offers Up to $1.2 Billion for U.S. Shipbuilding Business 
The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.
